Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study The DNA damage response (DDR) ...
Poly adenosine diphosphate-ribose polymerase inhibitors, an important class of anticancer drugs, employ synthetic lethality strategy and are particularly effective against cancers with genetic ...
Researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing ...
Poly(ADP-ribose) polymerase 1 (PARP-1; ARTD1) inhibitors have been described in a Protheragen Inc. patent as potentially useful for the treatment of cancer, neurodegeneration, cardiovascular disorders ...
Control 55.4 ± 0.7 56.6 ± 1.3 36.5 ± 0.4 37.1 ± 0.5 Control + ABA 55.6 ± 0.7 57.3 ± 1.1 36.5 ± 0.5 37.2 ± 0.4 Control + ISO 56.9 ± 1.8 57.2 ± 1.2 36.7 ± 0. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback